0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Letters |

Guest Authorship, Mortality Reporting, and Integrity in Rofecoxib Studies—Reply

Joseph S. Ross, MD, MHS; David S. Egilman, MD, MPH; Harlan M. Krumholz, MD, SM
JAMA. 2008;300(8):900-906. doi:10.1001/jama.300.8.904-c.
Text Size: A A A
Published online

Extract

In Reply: Drs FitzGerald, Patrono, and Hawkey write that review papers they authored were inappropriately included in the Table in our article, explaining that their articles were independently authored without discussion of their content with Merck before publication. The Table, as stated in its legend and in the text of the article, includes articles identified from internal documents,1,2 as well as other articles by investigators identified within internal documents. Articles by such investigators were found by searching MEDLINE, as we described. All of these articles were examined to better understand patterns of disclosure, as we believed that either their mention within internal documents or the mention of specific investigators suggested that Merck was aware of the publication and perhaps had provided support for the project. Correspondence with Merck, acknowledged by FitzGerald and Patrono, led to the identification of their articles using MEDLINE. To our knowledge, these articles were not discussed with medical publishing companies and no such claims were made within our study. Hawkey was identified from a publication status report that proposed him as a first author of 1 clinical trial and 1 review article and designated a Merck employee as author of the manuscripts' first drafts.1 We identified both articles using MEDLINE,3,4 as well as 2 other clinical trial articles and the 4 review manuscripts in question.

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

August 27, 2008
Kent R. Johnson, MD; Marissa N. D. Lassere, MBBS, PhD
JAMA. 2008;300(8):900-906. doi:10.1001/jama.300.8.900-a.
August 27, 2008
Garret A. FitzGerald, MD
JAMA. 2008;300(8):900-906. doi:10.1001/jama.300.8.900-b.
August 27, 2008
Carlo Patrono, MD
JAMA. 2008;300(8):900-906. doi:10.1001/jama.300.8.901-a.
August 27, 2008
Christopher J. Hawkey, DM
JAMA. 2008;300(8):900-906. doi:10.1001/jama.300.8.901-b.
August 27, 2008
Steven Ferris, PhD; Douglas Galasko, MD; Louis Kirby, MD
JAMA. 2008;300(8):900-906. doi:10.1001/jama.300.8.901-c.
August 27, 2008
Richard Balon, MD
JAMA. 2008;300(8):900-906. doi:10.1001/jama.300.8.902-a.
August 27, 2008
Serban-Dan Costa, MD, PhD
JAMA. 2008;300(8):900-906. doi:10.1001/jama.300.8.902-b.
August 27, 2008
Hervé Maisonneuve, MD
JAMA. 2008;300(8):900-906. doi:10.1001/jama.300.8.903-a.
August 27, 2008
Hean T. Ong, MBBS; Jin S. Cheah, MBBS
JAMA. 2008;300(8):900-906. doi:10.1001/jama.300.8.903-b.
August 27, 2008
Peter A. Lachenbruch, PhD; Ronald Wasserstein, PhD
JAMA. 2008;300(8):900-906. doi:10.1001/jama.300.8.904-a.
August 27, 2008
Bruce M. Psaty, MD, PhD; Richard A. Kronmal, PhD
JAMA. 2008;300(8):900-906. doi:10.1001/jama.300.8.904-b.
August 27, 2008
Catherine D. DeAngelis, MD, MPH; Phil B. Fontanarosa, MD, MBA
JAMA. 2008;300(8):900-906. doi:10.1001/jama.300.8.905.
CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();